X
Cookies help us improve your website experience.
By using our website, you agree to our use of cookies.


Latest Post

July 10, 2019

Intended Use and Packaging Risks for Compounding Pharmacies (503Bs)

In 2015, the FDA shed light on a problematic practice within the healthcare industry involving improper, off-label use of syringes as closed container storage systems for compounded or repackaged drugs. The incidents cited revealed that interaction with rubber plungers in syringes that were not cleared for the purpose of closed container storage resulted in the loss of potency of several drugs when administration was delayed.<sup>1</sup>
Amy Kim

Amy Kim

Sr. Specialist, Scientific Communications, SA & TS

Categories

Search the Blog

Archive

{1}

{2}
{3}

{4}

  • Previous Posts
    Elastomers

    June 25, 2019

    Bromobutyl versus Chlorobutyl Rubber Formulations - General Aspects

    Heike Kofler

    Dr. Heike Kofler

    Manager, Technical Customer Support Europe

    NovaPure Stoppers and Plungers

    August 01, 2018

    Elastomer Fundamentals: What Makes a Rubber Formulation?

    Bjoern Henze

    Bjoern Henze

    Manager, Technical Customer Service

    Stoppers and Plungers

    June 29, 2018

    Changes in the European Pharmacopoeia 9.5 Chapter 3.2.9

    Bettine Boltres

    Bettine Boltres

    Manager, Technical Account, TCS EU

    Blow back Vial Drawing

    September 23, 2015

    Convenient Sourcing in Small Quanitities

    West Pharma

    Whitney Winters

    Director, Sales, Emerging Bio, NA

    Load more